September 1, 2015 by CC • Commentary

A few weeks ago, when the M&A frenzy in Biotech was demonstrating toppy behavior we posted a Name That Trade in the S&P biotech etf XBI. At the time it was up 37% on the …

Continue reading
August 6, 2015 by Dan • Commentary

It’s fairly indisputable, there is a sort of rolling sell-off going on in prior bull market leaders. All you need to do is look at the recent 15% declines in stocks like Apple (AAPL) and …

Continue reading
May 6, 2015 by Dan • Commentary

Biotech stocks have in focus of late, as they appear to be ground zero for concerns of an equity bubble as a result of strong performance, non-stop m&a activity, recent volatility and valuation concerns among …

Continue reading